Vancouver, Canada

Kevin Albert Heyries

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 6.8

ph-index = 1


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kevin Albert Heyries: Innovator in Lymphocyte Receptor Research

Introduction

Kevin Albert Heyries is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of immunology, particularly in the study of lymphocyte receptor chains. With a total of 4 patents to his name, Heyries is recognized for his innovative approaches to understanding immune responses.

Latest Patents

Heyries' latest patents focus on advanced methods for determining lymphocyte receptor chain pairs. These patents provide high-throughput sequencing methods that study the diversity and functionality of lymphocyte receptor chains. Specifically, the methods are designed to identify one or more lymphocyte receptor chain pairs in a sample, enhancing the understanding of functional chain pairs.

Career Highlights

Kevin Albert Heyries is affiliated with the University of British Columbia, where he continues to advance research in his field. His work has garnered attention for its potential applications in immunotherapy and disease treatment. Heyries' innovative methods are paving the way for new discoveries in lymphocyte functionality.

Collaborations

Some of his notable coworkers include Daniel Jay Da Costa and Marketa Ricicova. Their collaborative efforts contribute to the ongoing research and development in the area of lymphocyte receptor studies.

Conclusion

Kevin Albert Heyries stands out as a prominent inventor in the realm of immunology, with a focus on lymphocyte receptor chains. His contributions are vital for advancing our understanding of immune responses and potential therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…